These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19013083)

  • 1. Prevention of autoimmunity and control of recall response to exogenous antigen by Fas death receptor ligand expression on T cells.
    Mabrouk I; Buart S; Hasmim M; Michiels C; Connault E; Opolon P; Chiocchia G; Lévi-Strauss M; Chouaib S; Karray S
    Immunity; 2008 Dec; 29(6):922-33. PubMed ID: 19013083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Fas/FasL interactions in the regulation of B cell function.
    Jacobson BA; Rothstein TL; Marshak-Rothstein A
    Behring Inst Mitt; 1996 Oct; (97):185-99. PubMed ID: 8950476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity.
    Siegel RM; Chan FK; Chun HJ; Lenardo MJ
    Nat Immunol; 2000 Dec; 1(6):469-74. PubMed ID: 11101867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells.
    Modiano JF; Sun J; Lang J; Vacano G; Patterson D; Chan D; Franzusoff A; Gianani R; Meech SJ; Duke R; Bellgrau D
    Clin Immunol; 2004 Jul; 112(1):54-65. PubMed ID: 15207782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism.
    Dranitzki-Elhalel M; Huang JH; Sasson M; Rachmilewitz J; Parnas M; Tykocinski ML
    Int Immunol; 2007 Apr; 19(4):355-63. PubMed ID: 17314083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of alphabeta and gammadelta T cells to the generation of primary immunoglobulin G-driven autoimmune response in immunoglobulin- mu-deficient/lpr mice.
    Seagal J; Melamed D
    Immunology; 2004 Jun; 112(2):265-73. PubMed ID: 15147570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cells engineered to express Fas ligand suppress pre-sensitized antigen-specific T cell responses in vivo.
    Kosiewicz MM; Krishnan A; Worthington MT; Matriano JA; Ross WG
    Eur J Immunol; 2002 Jun; 32(6):1679-87. PubMed ID: 12115651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engagement of CD44 up-regulates Fas ligand expression on T cells leading to activation-induced cell death.
    Nakano K; Saito K; Mine S; Matsushita S; Tanaka Y
    Apoptosis; 2007 Jan; 12(1):45-54. PubMed ID: 17136494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation-induced cell death in T cells and autoimmunity.
    Zhang J; Xu X; Liu Y
    Cell Mol Immunol; 2004 Jun; 1(3):186-92. PubMed ID: 16219166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive.
    Kim SH; Bianco N; Menon R; Lechman ER; Shufesky WJ; Morelli AE; Robbins PD
    Mol Ther; 2006 Feb; 13(2):289-300. PubMed ID: 16275099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity.
    Drappa J; Vaishnaw AK; Sullivan KE; Chu JL; Elkon KB
    N Engl J Med; 1996 Nov; 335(22):1643-9. PubMed ID: 8929361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpressed exogenous IL-4 And IL-10 paradoxically regulate allogenic T-cell and cardiac myocytes apoptosis through FAS/FASL pathway.
    Furukawa H; Oshima K; Tung T; Cui G; Laks H; Sen L
    Transplantation; 2008 Feb; 85(3):437-46. PubMed ID: 18301335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective T cell activation and autoimmune disorder in Stra13-deficient mice.
    Sun H; Lu B; Li RQ; Flavell RA; Taneja R
    Nat Immunol; 2001 Nov; 2(11):1040-7. PubMed ID: 11668339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells.
    Bergtold A; Desai DD; Gavhane A; Clynes R
    Immunity; 2005 Nov; 23(5):503-14. PubMed ID: 16286018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell antigen receptor signaling requirements for targeting antigen to the MHC class II presentation pathway.
    Clark MR; Massenburg D; Siemasko K; Hou P; Zhang M
    Curr Opin Immunol; 2004 Jun; 16(3):382-7. PubMed ID: 15134789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes.
    Bosque A; Aguiló JI; del Rey M; Paz-Artal E; Allende LM; Naval J; Anel A
    J Leukoc Biol; 2008 Aug; 84(2):488-98. PubMed ID: 18483205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunology. Autoreactive B cells migrate into T cell territory.
    Fu YX; Storb U
    Science; 2002 Sep; 297(5589):2006-8. PubMed ID: 12242429
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoimmune regulator controls T cell help for pathogenetic autoantibody production in collagen-induced arthritis.
    Campbell IK; Kinkel SA; Drake SF; van Nieuwenhuijze A; Hubert FX; Tarlinton DM; Heath WR; Scott HS; Wicks IP
    Arthritis Rheum; 2009 Jun; 60(6):1683-93. PubMed ID: 19479827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B lymphocytes are required for development and treatment of autoimmune diseases.
    Youinou P; Jamin C; Pers JO; Berthou C; Saraux A; Renaudineau Y
    Ann N Y Acad Sci; 2005 Jun; 1050():19-33. PubMed ID: 16014517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity.
    Stranges PB; Watson J; Cooper CJ; Choisy-Rossi CM; Stonebraker AC; Beighton RA; Hartig H; Sundberg JP; Servick S; Kaufmann G; Fink PJ; Chervonsky AV
    Immunity; 2007 May; 26(5):629-41. PubMed ID: 17509906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.